Tropomyosin Receptor Kinases Inhibitors [MoA] - N0000193859
Pharmacologic Class Information
Pharmacologic Code | N0000193859 |
Pharmacologic Name | Tropomyosin Receptor Kinases Inhibitors |
Pharmacologic Uses |
|
Pharmacologic Concept | Mechanisms of Action - [MoA] |
Pharmacologic Concept Description | This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept. |
NDC Products with Tropomyosin Receptor Kinases Inhibitors
The table contains 7 products whose active ingredient are classified under the same pharmacologic class Tropomyosin Receptor Kinases Inhibitors [MoA].
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
50419-390 | Vitrakvi | Non-Proprietary Name: Larotrectinib | Capsule | Oral | Bayer Healthcare Pharmaceuticals Inc. | ACTIVE | |
50419-392 | Vitrakvi | Non-Proprietary Name: Larotrectinib | Solution, Concentrate | Oropharyngeal | Bayer Healthcare Pharmaceuticals Inc. | ACTIVE | |
50419-391 | Vitrakvi | Non-Proprietary Name: Larotrectinib | Capsule | Oral | Bayer Healthcare Pharmaceuticals Inc. | ACTIVE | |
50419-393 | Vitrakvi | Non-Proprietary Name: Larotrectinib | Solution, Concentrate | Oropharyngeal | Bayer Healthcare Pharmaceuticals Inc. | ACTIVE | |
71777-390 | Vitrakvi | Non-Proprietary Name: Larotrectinib | Capsule | Oral | Loxo Oncology, Inc. | ACTIVE | |
71777-391 | Vitrakvi | Non-Proprietary Name: Larotrectinib | Capsule | Oral | Loxo Oncology, Inc. | ACTIVE | |
71777-392 | Vitrakvi | Non-Proprietary Name: Larotrectinib | Solution | Oral | Loxo Oncology, Inc. | ACTIVE |